[Elsevier] Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study |
|
This post will be closed automatically in 2026-07-07 02:32
Reward10points
|
| |
20
Aligning ESG talk and walk: The effect of corporate site visits on ESG decoupling
10
The influence of food matrix on the stability and bioavailability of phytochemicals: A comprehensive review
10
Impact of high versus low fraction of inspired oxygen for anaesthetic washout and extubation on postoperative pulmonary atelectasis formation and oxygenation: a randomised controlled trial
30
Ketosis-Prone Type 2 Diabetes Mellitus: 3 Decades of Clinical, Pathophysiologic, and Therapeutic Insights
20
The Art of Estimating Cardiorespiratory Fitness
